Vistagen Therapeutics (VTGN) Short Interest Ratio & Short Volume

$4.44
-0.11 (-2.42%)
(As of 05/17/2024 ET)

Vistagen Therapeutics Short Interest Data

Current Short Volume
1,180,000 shares
Previous Short Volume
1,290,000 shares
Change Vs. Previous Month
-8.53%
Dollar Volume Sold Short
$5.70 million
Short Interest Ratio / Days to Cover
4.6
Last Record Date
April 30, 2024
Outstanding Shares
27,020,000 shares
Float Size
24,300,000 shares
Short Percent of Float
4.86%
Today's Trading Volume
76,451 shares
Average Trading Volume
168,523 shares
Today's Volume Vs. Average
45%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Vistagen Therapeutics ?

Sign up to receive the latest short interest report for Vistagen Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

VTGN Short Interest Over Time

VTGN Days to Cover Over Time

VTGN Percentage of Float Shorted Over Time

Vistagen Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/20241,180,000 shares $5.70 million -8.5%4.9%4.6 $4.83
4/15/20241,290,000 shares $6.13 million +0.8%5.3%4.9 $4.75
3/31/20241,280,000 shares $6.76 million -3.8%5.3%4.4 $5.28
3/15/20241,330,000 shares $5.39 million -8.9%5.5%4.7 $4.05
2/29/20241,460,000 shares $7.46 million -15.1%6.0%3.6 $5.11
2/15/20241,720,000 shares $9.32 million +27.4%7.1%4.1 $5.42
1/31/20241,350,000 shares $6.45 million +16.4%5.6%2.6 $4.78
1/15/20241,160,000 shares $6.32 million -28.8%4.8%2.1 $5.45
12/31/20231,630,000 shares $8.38 million +37.0%6.7%2.7 $5.14
12/15/20231,190,000 shares $5.93 million -4.8%4.9%1.8 $4.98
11/30/20231,250,000 shares $4.49 million -21.4%5.1%2.1 $3.59
11/15/20231,590,000 shares $5.23 million +2.6%6.4%2.7 $3.29
10/31/20231,550,000 shares $4.93 million +14.8%7.0%1.4 $3.18
10/15/20231,350,000 shares $4.64 million +61.6%6.1%0.7 $3.44
9/30/2023835,300 shares $4.38 million +16.8%3.5%0.4 $5.24
9/15/2023715,100 shares $4.25 million -31.9%7.7%0.4 $5.95
8/31/20231,050,000 shares $5.60 million -18.0%11.3%0.6 $5.33
8/15/20231,280,000 shares $8.04 million +132.2%13.8%0.7 $6.28
7/31/2023551,300 shares $1.00 million +18.1%7.0%0.4 $1.82
7/15/2023467,000 shares $826,590.00 +36.3%6.0%2.3 $1.77
6/30/2023342,600 shares $640,662.00 -50.2%4.4%1.7 $1.87
6/15/2023687,500 shares $1.43 million +72.2%9.5%3.2 $2.08
5/31/2023399,200 shares $1.70 million -96.8%N/A2.3 $4.26
5/15/202312,450,000 shares $1.75 million -12.0%N/A3.6 $0.14
4/30/202314,150,000 shares $1.98 million -10.6%N/A3 $0.14
4/15/202315,820,000 shares $2.19 million +25.0%N/A2.9 $0.14
3/31/202312,660,000 shares $1.58 million +47.7%N/A2.1 $0.12
3/15/20238,570,000 shares $1.31 million +17.4%N/A1.2 $0.15
2/28/20237,300,000 shares $1.28 million -14.9%N/A1 $0.18
2/15/20238,580,000 shares $1.70 million -15.8%N/A1.1 $0.20
1/31/202310,190,000 shares $2.64 million -17.8%N/A1.5 $0.26
1/15/202312,400,000 shares $1.98 million -19.7%N/A2.1 $0.16
12/30/202215,440,000 shares $1.59 million +36.9%N/A2.5 $0.10
12/15/202211,280,000 shares $1.27 million +24.2%N/A2.1 $0.11
11/30/20229,080,000 shares $1.25 million -1.2%N/A1.7 $0.14
11/15/20229,190,000 shares $1.46 million +13.7%N/A1.5 $0.16
10/31/20228,080,000 shares $1.07 million +26.5%4.6%0.9 $0.13
10/15/20226,390,000 shares $713,124.00 +12.9%3.6%0.5 $0.11
9/30/20225,660,000 shares $860,886.00 +18.4%3.2%0.4 $0.15
9/15/20224,780,000 shares $916,326.00 -12.8%2.7%0.3 $0.19
get a piece of the profit from this land (Ad)

This isn’t the prettiest land on earth. But it might be the most valuable. And you don’t have to own, lease, or rent any land.

Click here to see my #1 investment for 2024.

VTGN Short Interest - Frequently Asked Questions

What is Vistagen Therapeutics' current short interest?

Short interest is the volume of Vistagen Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 1,180,000 shares of VTGN short. 4.86% of Vistagen Therapeutics' shares are currently sold short. Learn More on Vistagen Therapeutics' current short interest.

What is a good short interest ratio for Vistagen Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. VTGN shares currently have a short interest ratio of 5.0. Learn More on Vistagen Therapeutics's short interest ratio.

What is a good short interest percentage for Vistagen Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.86% of Vistagen Therapeutics' floating shares are currently sold short.

Is Vistagen Therapeutics' short interest increasing or decreasing?

Vistagen Therapeutics saw a drop in short interest in April. As of April 30th, there was short interest totaling 1,180,000 shares, a drop of 8.5% from the previous total of 1,290,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Vistagen Therapeutics' float size?

Vistagen Therapeutics currently has issued a total of 27,020,000 shares. Some of Vistagen Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Vistagen Therapeutics currently has a public float of 24,300,000 shares.

How does Vistagen Therapeutics' short interest compare to its competitors?

4.86% of Vistagen Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Vistagen Therapeutics: DiaMedica Therapeutics Inc. (0.48%), Coya Therapeutics, Inc. (1.41%), Nuvectis Pharma, Inc. (13.15%), FibroGen, Inc. (6.96%), Adagene Inc. (0.04%), Amylyx Pharmaceuticals, Inc. (18.07%), OptiNose, Inc. (5.24%), Context Therapeutics Inc. (0.05%), Karyopharm Therapeutics Inc. (14.59%), Immunic, Inc. (3.13%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks.

What does it mean to sell short Vistagen Therapeutics stock?

Short selling VTGN is an investing strategy that aims to generate trading profit from Vistagen Therapeutics as its price is falling. VTGN shares are trading down $0.11 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Vistagen Therapeutics?

A short squeeze for Vistagen Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of VTGN, which in turn drives the price of the stock up even further.

How often is Vistagen Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VTGN, twice per month. The most recent reporting period available is April, 30 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:VTGN) was last updated on 5/18/2024 by MarketBeat.com Staff

From Our Partners